at least 9,000 rohingya were killed in rakhine state from august 25 to september 24, according to doctors without borders.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
worried about how helen was doing after doctors performed surgery on her colon the same day he was admitted, robert, whose condition stabilized, had a simple request for his nurse:
.
.
